Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PF-06940434 |
Trade Name | |
Synonyms | PF06940434|PF 06940434 |
Drug Descriptions |
PF-06940434 is an integrin alpha v beta 8 antagonist that prevents the activation of TGFB1, leading to an anti-tumor response (Mar 2020). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C172097 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PF-06801591 + PF-06940434 | PF-06801591 PF-06940434 | 0 | 1 |
PF-06940434 | PF-06940434 | 0 | 1 |